For companies involved in pharmaceutical packaging, 2018 looks like it will be a year of scrambling to meet new regulations on serialization, safety and security, while at the same time responding to market demands for personalized care and generational requirements.
Driven by increasingly complex supply chains, a lack of enforcement capacity, the expansion of ecommerce and more sophisticated counterfeiters and counterfeiting methods, the FDA estimates that approximately 10% of all pharmaceuticals currently sold globally are illicit.
The medicine or device may be a home-run product, but if consumers aren’t using the product correctly, it has little chance of success. And if the consumers cannot even open the package to get to the product inside, it has zero chance.